Skin cancer after heart transplantation: a systematic review.

IF 2.6 4区 医学 Q2 DERMATOLOGY Anais brasileiros de dermatologia Pub Date : 2024-11-16 DOI:10.1016/j.abd.2024.05.004
Nathalia Hoffmann Guarda Aguzzoli, Ana Laura Bueno, Yağmur Halezeroğlu, Renan Rangel Bonamigo
{"title":"Skin cancer after heart transplantation: a systematic review.","authors":"Nathalia Hoffmann Guarda Aguzzoli, Ana Laura Bueno, Yağmur Halezeroğlu, Renan Rangel Bonamigo","doi":"10.1016/j.abd.2024.05.004","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cancer is an important cause of morbidity and mortality after solid organ transplants. Skin cancer is the most prevalent non-lymphoid malignancy occurring during heart transplantation follow-up. Due to the complexity of immunosuppressive therapy and the high prevalence and incidence of skin cancer in this population, dermatologists play an important role in the short and long-term follow-up of heart transplant recipients.</p><p><strong>Objectives: </strong>The goal of this study is to present data from a systematic literature review focusing on the occurrence of skin cancer in patients who have undergone heart transplantation.</p><p><strong>Methods: </strong>The authors conducted a systematic review of the literature in the EMBASE and PubMed databases from August to September 2021 to investigate the incidence of skin cancer in heart transplant patients. The authors selected retrospective and prospective cohort studies presenting data on the frequency of skin cancer in patients following heart transplantation. Exclusion criteria included articles that did not stratify the organ transplant type and studies that did not evaluate the frequency of skin cancer in the specific population.</p><p><strong>Results: </strong>Based on the search strategy, the authors found 2589 studies, out of which 37 were eligible for inclusion in this study. Provided data are from 20 different countries, over the period 1974 to 2015. Incidence of non-melanoma skin cancer (NMSC) ranges from 0.97% to 52.8%. The incidence of squamous cell carcinoma (SCC) ranges from 1.19% to 89% and the incidence of basal cell carcinoma (BCC) ranges from 2% to 63%. Malignant Melanoma (MM) incidence ranges from 0.94% to 4.6% STUDY LIMITATIONS: The analysis involved an exclusive focus on heart transplant patients, and the statistical analysis of the sample may have been hampered. The significant heterogeneity among the studies emerged as a challenge during the analysis of the results. Furthermore, the study is limited by variations in follow-up periods among the included studies.</p><p><strong>Conclusion: </strong>Although gathering methodologically heterogeneous data, this systematic review was able to show the epidemiological importance of skin cancer in heart transplant patients. This study reinforces the important role dermatologists play in the short and long-term follow-up of heart transplant patients.</p>","PeriodicalId":7787,"journal":{"name":"Anais brasileiros de dermatologia","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anais brasileiros de dermatologia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.abd.2024.05.004","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cancer is an important cause of morbidity and mortality after solid organ transplants. Skin cancer is the most prevalent non-lymphoid malignancy occurring during heart transplantation follow-up. Due to the complexity of immunosuppressive therapy and the high prevalence and incidence of skin cancer in this population, dermatologists play an important role in the short and long-term follow-up of heart transplant recipients.

Objectives: The goal of this study is to present data from a systematic literature review focusing on the occurrence of skin cancer in patients who have undergone heart transplantation.

Methods: The authors conducted a systematic review of the literature in the EMBASE and PubMed databases from August to September 2021 to investigate the incidence of skin cancer in heart transplant patients. The authors selected retrospective and prospective cohort studies presenting data on the frequency of skin cancer in patients following heart transplantation. Exclusion criteria included articles that did not stratify the organ transplant type and studies that did not evaluate the frequency of skin cancer in the specific population.

Results: Based on the search strategy, the authors found 2589 studies, out of which 37 were eligible for inclusion in this study. Provided data are from 20 different countries, over the period 1974 to 2015. Incidence of non-melanoma skin cancer (NMSC) ranges from 0.97% to 52.8%. The incidence of squamous cell carcinoma (SCC) ranges from 1.19% to 89% and the incidence of basal cell carcinoma (BCC) ranges from 2% to 63%. Malignant Melanoma (MM) incidence ranges from 0.94% to 4.6% STUDY LIMITATIONS: The analysis involved an exclusive focus on heart transplant patients, and the statistical analysis of the sample may have been hampered. The significant heterogeneity among the studies emerged as a challenge during the analysis of the results. Furthermore, the study is limited by variations in follow-up periods among the included studies.

Conclusion: Although gathering methodologically heterogeneous data, this systematic review was able to show the epidemiological importance of skin cancer in heart transplant patients. This study reinforces the important role dermatologists play in the short and long-term follow-up of heart transplant patients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
心脏移植后的皮肤癌:系统回顾。
背景:癌症是实体器官移植后发病和死亡的重要原因。皮肤癌是心脏移植后续治疗中最常见的非淋巴恶性肿瘤。由于免疫抑制治疗的复杂性以及皮肤癌在这一人群中的高流行率和发病率,皮肤科医生在心脏移植受者的短期和长期随访中发挥着重要作用:本研究的目的是通过系统性文献综述提供数据,重点关注心脏移植患者皮肤癌的发生情况:作者于 2021 年 8 月至 9 月对 EMBASE 和 PubMed 数据库中的文献进行了系统性回顾,以调查心脏移植患者皮肤癌的发病率。作者选择了一些回顾性和前瞻性队列研究,这些研究提供了心脏移植患者皮肤癌发病率的数据。排除标准包括未对器官移植类型进行分层的文章,以及未评估特定人群皮肤癌发病率的研究:根据搜索策略,作者找到了 2589 项研究,其中 37 项符合纳入本研究的条件。提供的数据来自 20 个不同国家,时间跨度为 1974 年至 2015 年。非黑色素瘤皮肤癌(NMSC)的发病率从 0.97% 到 52.8% 不等。鳞状细胞癌(SCC)的发病率从1.19%到89%不等,基底细胞癌(BCC)的发病率从2%到63%不等。恶性黑色素瘤 (MM) 的发病率从 0.94% 到 4.6% 不等:分析仅针对心脏移植患者,样本的统计分析可能受到影响。在对结果进行分析时,各研究之间存在明显的异质性,这也是一个挑战。此外,这项研究还受到所纳入研究的随访期不同的限制:尽管收集到的数据在方法上存在差异,但这篇系统综述能够显示皮肤癌在心脏移植患者中的流行病学重要性。这项研究加强了皮肤科医生在心脏移植患者短期和长期随访中的重要作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.40
自引率
0.00%
发文量
184
审稿时长
32 days
期刊介绍: The journal is published bimonthly and is devoted to the dissemination of original, unpublished technical-scientific study, resulting from research or reviews of dermatological topics and related matters. Exchanges with other publications may be accepted.
期刊最新文献
Exploring the reality of exosomes in dermatology. Clinical and epidemiological characterization of demodicosis cases in the pediatric population at the Hospital Clinic of the University of Chile (2013‒2020). Skin cancer after heart transplantation: a systematic review. The exposome impact on hair health: etiology, pathogenesis and clinical features ‒ Part I. Brazilian experience with oral atenolol in the treatment of infantile hemangiomas.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1